Mylan Gets Order Blocking Glaxo Sale of Generic Paxil
This article is for subscribers only.
Mylan Inc., the generic-drug maker with an exclusive agreement to sell a copy of GlaxoSmithKline Plc’s Paxil CR, said it won a temporary court order blocking Apotex Inc. from also selling the antidepressant medicine.
Mylan, which says it has a licensing agreement, claimed in a lawsuit yesterday that Glaxo is letting Apotex sell Paxil CR under the chemical name paroxetine hydrochloride. The order today by a federal court in Trenton, New Jersey, blocks Apotex from “using, offering to sell, selling or shipping or otherwise launching” generic Paxil CR, Mylan said in a statement.